article · Journal of Radioanalytical and Nuclear Chemistry
Abstract Rhenium-188 ( 188 Re) is a β − emitting radionuclide with a significant potential for use in targeted radionuclide therapy. The current study set out to assess the possibility of producing 188 Re through double neutron capture on 186 W at the Egyptian Second Research Reactor (ETRR-2). Using the MCNPX2.7.0 code, the neutron activation of a naturally occurring tungsten target positioned at the highest thermal neutron flux was simulated. There was a little discrepancy between the calculated results and the experimental data. The feasibility of using Bio-Rex 5 anionic resin for developing an 188 W/ 188 Re chromatographic generator was investigated using static and dynamic studies. Our results showed that a high adsorption capacity of 240 mg/g towards WO 4 2− was attained. Additionally, more than 97.3 ± 0.6% of the 188 Re could be recovered from the generator in the first 3 mL, with high chemical, radiochemical, and radionuclidic purities adequate for radiopharmaceutical preparations as well as clinical applications.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s10967-024-09781-3
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.